Farletuzumab

{
  "id": "MLC-T-ONC-013532",
  "term": "Farletuzumab",
  "field": "Oncology and biomedicine",
  "definition": "A humanized, immunoglobulin G1 monoclonal antibody with potential antitumor activity. Farletuzumab specifically targets at glycoprotein 3 (GP-3), a cell surface antigen that is overexpressed on many epithelial-derived cancer cells. Upon binding to the GP-3 antigen, farletuzumab triggers a host immune response against GP-3 expressing cells resulting in cell lysis.",
  "synonyms": [
    "anti-GP-3 monoclonal antibody"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/farletuzumab/"
}